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Abstract
Introduction Glycosylation is an important component for a
number of biological processes and is perhaps the most
abundant and complicated of the known post-translational
modifications found on proteins.
Methods This work combines two-dimensional (2-D) poly-
acrylamide gel electrophoresis and lectin blotting to map
the salivary glycome and mass spectrometry to identity the
proteins that are associated with the glycome map. A panel
of 15 lectins that recognize six sugar-specific categories
was used to visualize the type and extent of glycosylation in
saliva from two healthy male individuals. Lectin blots were
compared to 2-D gels stained either with Sypro Ruby
(protein stain) or Pro-Q Emerald 488 (glycoprotein stain).
Results Each lectin shows a distinct pattern, even those
belonging to the same sugar-specific category. In addition,
the glycosylation profiles generated from the lectin blots
show that most salivary proteins are glycosylated and that
the profiles are more widespread than is demonstrated by
the glycoprotein-stained gel. Finally, the coreactivity
between lectins was measured to determine what types of
glycan structures are associated with one another and also
the population variation of the lectin reactivity for 66
individuals were reported.
Conclusions This starting 2-D gel glycosylation reference
map shows that the scientifically accepted, individual
oligosaccharide variability is not limited to a few large
glycoproteins such as MUC5B, but are found on most
members of the salivary proteome. Finally, in order to see
the full range of oligosaccharide distribution, multiple
reagents or lectins are needed.
Keywords Glycosylation . Human whole saliva . Lectin
blotting . Two-dimensional gel electrophoresis
Introduction
Saliva is the oral fluid that lubricates, buffers, and protects oral
tissues against decay, damage, and microbial inflammation
and facilitates the remineralization of teeth. Saliva consists
primarily of water, minerals, electrolytes, buffer, and proteins
that are secreted by three major glands (parotid, submandib-
ular, sublingual) and by numerous minor glands in the lip,
cheek, tongue, and palate. In addition, saliva contains
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microbes, epithelial cells, nasal and bronchial secretions, and
serum products. These components can provide clues to local
and/or systemic diseases and disorders of the human body [1].
Therefore, numerous studies have sought to develop a
complete catalog of the proteins and peptides found in
human saliva [2–12]. However, proteins are only one chapter
in gaining a comprehensive catalog of all the components in
saliva; another is to characterize the post-translational
modifications of the proteins and peptides that compose the
human salivary catalog.
Glycosylation is the most abundant and among the most
complicated of the known post-translational modifications
found on proteins [13–15]. It plays an important role in cell
adhesion, cell trafficking, protease protection, signaling,
protein structure, and many other biological functions [13,
16]. With more than 50% of all proteins estimated to be
glycosylated [17] and the mammalian glycome repertoire
estimated to be hundreds and thousands of glycan structures
[13], it is not surprising that changes in the oligosaccharide
structure have been linked to many diseases, including
autoimmune diseases [18], cancer [19], pre-term labor [20],
rheumatoid arthritis [21], and virus infection [13].
Saliva is a rich source of both N- and O-linked glyco-
proteins, which play an important role in the maintenance of
oral health and protection of teeth [22, 23]. Several
glycoproteins bind to a variety of bacteria and either aid or
prevent the adherence of bacteria to mucosal and tooth
surfaces [24–26]. Other glycoprotein functions include
lubricating tooth surfaces [23] and possibly protecting
proteins from proteolytic attack [27]. Our laboratory has
previously identified a number of Asn-linked glycoproteins
in human whole saliva and salivary glandular fluid [28, 29]
using the N-linked glycopeptides capture method [30] that
employs hydrazide chemistries and resins to capture glyco-
proteins. Following the enzymatic cleavage of the N-linked
glycopeptides with N-glycosidase F and trypsin digestion,
glycoproteins of the formerly N-linked glycopeptides were
identified by mass spectrometry (MS) analysis. Using this
strategy, we identified N-glycopeptides representing 77
unique N-glycoproteins in whole saliva and salivary glan-
dular fluid. However, further work needs to be done in
characterizing the glycosylation on those glycoproteins.
Lectins are nonenzymatic, carbohydrate-binding proteins
or glycoproteins that are found ubiquitously in nature.
These proteins bind reversibly to specific glycan structures.
Recognition of a particular monosaccharide is one of the
important factors determining the lectin specificity. Other
factors may include preference for either the α- or β-
anomer along with the recognition of specific linkage(s) for
a series of sugars. In addition, most lectins will interact
exclusively with the terminal nonreducing position in an
oligosaccharide; however, some lectins such as concanav-
alin A (ConA) and wheat germ agglutinin (WGA) bind to
internal sugars [31]. Because lectins are easily purified in
large quantities, they have become a useful tool for the
detection, isolation, and characterization of glycoconjugates
[32]. Besides their primary affinity, lectins do have
secondary affinities to different glycan structures. There-
fore, the structural information that is provided from the
binding of a particular lectin needs to be further validated
by other analytical techniques. By using a panel of lectins,
other members of the panel can help shed light onto
whether or not the binding of one lectin may actually be
due to its secondary affinity versus its primary affinity.
Even though lectins have both primary and secondary
affinities, the use of lectins to study glycoconjugates has a
long and productive history [33, 34].
Since post-translational modifications alter the apparent
molecular weight and isoelectric point of a protein, two-
dimensional (2-D) gel electrophoresis is a powerful tool for
examining variation of these types of modifications. For
example, gain or loss of glycosylation sites and differences
in the extent of branching and/or modifications in the
number of sialic acid residues bound to a particular protein
will change the spot pattern during 2-D gel electrophoresis.
Many times these modifications are observed as a “train” of
spots in the 2-D gels. By combining 2-D gel electrophore-
sis, lectin blotting, and identification by mass spectrometry,
we can correlate changes in the migration pattern of a
particular protein to possible changes in the glycoforms.
Any interesting spots would need further detailed analysis
(i.e., mass spectrometry) to identify all of the post-
translational modifications associated with a change in the
migration pattern.
A panel of 15 lectins (Table 1) from six monosaccharide-
specific categories (fucose (lectins AAL, PSA, and UEA I),
galactose (lectins JAC and Mal I), mannose (lectins ConA,
GNL, and HHL), N-acetyl-galactosamine (lectins BPL and
VVA), N-acetyl-glucosamine (lectins DSL, LEL, and
WGA), and sialic acid (lectins MAL II and SNA)) was
used to visualize the type and the extent of glycosylation.
The lectin blots were then compared to 2-D gels stained
either with Sypro Ruby total protein stain or Pro-Q Emerald
488 glycoprotein stain. Although lectin blotting has been
previously used in combination with 2-D gel electrophore-
sis [64–69], this is the first report using a comprehensive
lectin panel to profile the glycosylation pattern of a
particular proteome. Comparison of lectin 2-D blotting
maps provides an important first step in identifying inter-
esting candidate spots that could be used in the discovery of
disease-related biomarkers from human saliva. Further
studies would need to be carried out to fully characterize
the entire glycan moiety associated with these candidates
and to determine whether other post-translational modifi-
cations are also associated with the proteins identified from
that spot.
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Materials and Methods
Whole Saliva Collection and Preparation Saliva collection
was performed under UCLA IRB approval protocol number
04-09-051 titled “Human Salivary Proteome”. The subjects
in this study were two healthy, Asian males ranging in ages
of 33–35 and representing both A and B blood types. These
individuals rinsed their mouths three times with bottled
water to remove any food particles. Five minutes after the
oral rinse, the subjects were then asked to spit 10 ml of
resting (unstimulated) whole saliva into a 50-ml conical
tube containing 20 μl protease inhibitor cocktail for
mammalian tissues (Sigma-Aldrich, St. Louis, MO, USA).
The tube was kept on ice during the collection. Equal













50-Fold Fucose Fucose (α-1,6) N-acetylglucosamine or fucose (α-1,3) N-acetyllactosamine
residues [35]




Fucose Fucosyl (α-1,2) galactosyl (β-1,4) N-acetylglucosamine (β-1,6)-R and other
α-monofucosyl oligomers residues [36–38]







Galactose Sialic acid (α-2,3) galactosyl (β-1,4) N-acetylglucosamine residues,
tolerating substitution of N-acetyllactosamine with sialic acid at the 3
position of galactose [42, 43]
PSA Pisum sativum
agglutinin
7-Fold Mannose α-Mannose containing oligosaccharides with an N-acetylchitobiose-linked
α-fucose residue included in the sequence [38, 44–46]
ConA Concanavalin A 4-Fold Mannose and
glucose
Internal and nonreducing terminal α-mannose residues but also binds




25-Fold Mannose (α-1,3) Mannose residues, and unlike most mannose-binding lectins, it does





Mannose (α-1,3)- and (α-1,6)-linked polymannose structures and does not require






Galactosyl (β-1,3) N-acetylgalactosamine residues but also binds





α- or β-linked terminal N-acetylgalactosamine, especially a single α-N-






(β-1,4)-linked N-acetylglucosamine oligomers, preferring chitobiose or
chitotriose over a single N-acetylglucosamine residue and also binds well







(β-1,4)-linked N-acetylglucosamine oligomers preferring trimers and





Terminal (β-1,4)-linked N-acetylglucosamine dimers, galactosyl (β-1,4) N-
acetylglucosamine (β-1,3) repeats of large oligosaccharides and also binds





700-Fold Sialic acid N-Acetylneuraminic (α-2,3) galactosyl (β-1,3) N-acetylneuraminic (α-2,6)
N-acetylgalactosamine and other (α-2,3) linked sialic acid residues [62]
SNA Sambucus nigra
lectin
15-Fold Sialic acid Sialic acid attached to a terminal galactose in (α-2,6) linkage and to a lesser
degree (α-2,3) linkage [63]
Listed for each of the 15 lectins is the primary monosaccharide preference, which is typically based on what monosaccharide was the most
effective inhibitor of agglutination of erythrocytes or what carbohydrate-containing polymer was most effectively precipitated. Also listed are the
primary binding specificities for each of the lectins. For a more complete description of all glycan structures that are recognized by a particular
lectin, see the references provided. Whole saliva from 66 healthy individuals was examined using spot blot analysis to determine the population
variation for the reactivity of each of the lectins
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volumes of saliva from these two individuals were pooled
and then centrifuged for 10 min at 17,000×g, 4°C to
remove epithelial cells and other debris. The salivary
proteins were precipitated by adding 5× volume of ice-cold
100% ethanol. The tubes were mixed by inversion and
incubated overnight at −20°C. The precipitant was collected
the next day by centrifugation for 15 min at 20,000×g, 4°C.
The pellet was washed twice with room temperature (RT)
70% ethanol and centrifuged between each wash as
described in the precipitation step. The residual ethanol was
removed before the pellet was air-dried for 5 min at RT. The
pellet was resuspended by pipetting up and down in 7 M
urea, 2 M thiourea, 4% CHAPS, 0.2% Bio-Lyte 3/10
ampholyte, 0.0002% bromophenol blue, and 0.4% DTT.
Any insoluble material was removed by centrifugation for
5 min at 16,000×g, 4°C. The sample was aliquoted and stored
immediately at −80°C. One of the aliquots was used to
measure the protein concentration using a scaled-down
version of the Modified Bradford described by Ramagli [70].
Two-Dimensional Gel Electrophoresis A volume of 185 μl
of the saliva sample was passively loaded overnight at RTonto
an 11 cm Bio-Rad (Hercules, CA, USA) pH 3–10 NL
ReadyStrip IPG strip. The loaded samples contained either
50 μg (only for lectins AAL, ConA, JAC, PSA, SNA, and
WGA) or 250 μg of total protein. The isoelectric focusing was
performed for a total of 36 kV h (30 μA limit) using a Bio-Rad
PROTEAN IEF cell. The program for isoelectric focusing was
the following: 100 V (linear) for 4 h, 250 V (linear) for 2 h,
4,000 V (linear) for 5 h, 4,000 V (rapid) for 25,000 V h, and
250 V (rapid) for approximately 5 h. After focusing, the IPG
strips were first equilibrated with rocking for 20 min at RT in
50 mM Tris–HCl, pH 8.8, 7 M urea, 20% glycerol, 2% SDS,
and 2% DTT followed by 20 min with the same buffer with
2.5% iodoacetamide replacing DTT. The strips were then
rinsed with SDS-PAGE running buffer (25 mM Tris, pH 8.3,
192 mM glycine, and 0.1% SDS). The second dimension was
performed on a Bio-Rad 12.5% precast Criterion gel using a
Criterion Dodeca Cell at 10°C. The gels were electrophoresed at
a constant 40V for 10min followed by a constant 200Vuntil the
bromophenol blue front reached the bottom of the gel (∼65 min).
Gel Staining and Image Acquisition Following electropho-
resis, one of the gels was fixed for 2 h in 100 ml 10%
methanol and 7% acetic acid. This gel was stained
overnight in Sypro Ruby stain (Invitrogen-Molecular
Probes, Carlsbad, CA USA), diluted 1:2 in previously used
Sypro Ruby stain. The gel was then destained in fixer
solution for 48 h with two solution changes. Another gel
was fixed in 100 ml 50% methanol and 5% acetic acid.
After 2 h, the fixing solution was replaced, and the gel
continued fixing overnight. This gel was then stained with
Pro-Q Emerald 488 (Molecular Probes) according to the
instructions provided by the manufacturer. The maximum
time lengths were used in all the steps, and the last wash
step was carried out overnight.
The gels were imaged on a Typhoon 9410 Variable
Mode Imager (GE Healthcare, Piscataway, NJ, USA) at
200 nm resolution using the following excitation/emission
filters: 457 nm/610 nm BP 30 (Sypro Ruby) and 532 nm/
520 nm BP 40 (Pro-Q Emerald 488).
Spot Retrieval and Trypsin Digestion Protein spots from
the Sypro Ruby-stained gel were excised by a Proteome
Works Spot Cutter (Bio-Rad). The proteins were in-gel
trypsin digested overnight at 30°C using Montage In-Gel
DigestZP kit according to the instructions from Millipore
(Billerica, MA, USA). Peptides were eluted twice in 20 μl
0.1% trifluoroacetic acid and 50% acetonitrile (ACN) by
centrifugation for 15 s at 1,750×g, 4°C. The eluted peptides
were then dried down and stored at −20°C until they were
analyzed by liquid chromatography-tandem MS (LC-MS/
MS) with electrospray ionization.
Protein Identification by Liquid Chromatography-Mass
Spectrometry The dried peptides from spot numbers 19,
23, 24, 27, 28, 51, 62, 64, 65, 67–69, 76, 78, 81, 82, 88, 96,
and 106–174 from Fig. 1a and Supplemental Table were
resuspended in 0.1% formic acid and identified on an
Applied Biosystems (Foster City, CA, USA) QSTAR® XL
(QqTOF) mass spectrometer equipped with a nanoelectros-
pray (Protana, Odense, Denmark) interface to a Dionex-LC
Packings (Sunnyvale, CA, USA) nanoflow HPLC system.
The nano-LC was equipped with a set of custom pre-
columns (75 μm×10 mm) and column (75 μm×150 mm)
packed with Jupiter Proteo C12 resins (particle size 4 μm,
Phenomenex, Torrance, CA, USA). For each LC-MS/MS
run, typically 6 μl sample solution was first loaded onto the
pre-column and washed with the loading solvent, water
containing 0.1% formic acid, for 4 min before injection to
the LC column. The eluants used for the LC were (A) water
containing 0.1% formic acid and (B) 95% ACN/water
containing 0.1% formic acid. The flow was 200 nl/min, and
the following gradient was used: 3% B to 35% B in 25 min,
35% B to 80% B in 4 min and held at 80% B for 8 min.
The column was finally reequilibrated with 3% B for
15 min before the next run. For online MS and MS/MS
analyses, a Proxeon (Odense, Denmark) nano-bore stainless
steel online emitter (i.d. 30 μm) was used for spraying with
the voltage set at 1,900 V. Peptide product ion spectra were
automatically recorded during the LC-MS/MS runs by the
information-dependent analysis on the QSTAR® XL mass
spectrometer. Argon was employed as collision gas.
Collision energies for maximum fragmentation were auto-
matically calculated using empirical parameters based on
the charge and mass-to-charge ratio of the peptide.
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Peptides separated by HPLC underwent fragmentation in
the tandem mass spectrometer, and the resulting MS/MS
spectra were searched against the International Protein
Index for human database (version 3.03) using the Mascot
search engine (Matrix Science, London, UK). MudPIT
scoring with a threshold <0.05 ppm and ion score cut-off of
20 was used in the search parameters for positive protein
identification. The peptide assignments for all significant
hits were then manually validated. All other spots were
previously cut and identified by Hu et al. [8].
Lectin Blotting The gels were transferred for 2 h/4°C coldbox
onto nitrocellulose using a Hoefer (San Francisco, CA, USA)
TE62 transfer unit containing pre-chilled 25 mM Tris,
192 mM glycine, and 20% methanol. After transfer, the
nitrocellulose was allowed to air dry and was stored at RT
until use. The dried blots were incubated with continuous
agitation for 2 h at RT in TBST (50 mM Tris buffer at
pH 7.6, 150 mM NaCl, 0.1% Tween 20, and 0.01% sodium
azide) containing biotinylated lectin at the manufacturer’s
recommended concentration (Vector Laboratories, Burlin-
game, CA, USA and E-Y Laboratories, San Mateo, CA,
USA). Following two 10-min washes with TBST, the blot
was reacted for 20 min with avidin D–alkaline phosphatase
(Vector Laboratories). Two additional 10-min washes with
TBST were followed by two 10-min washes with TNM



























































































































































































































Fig. 1 Total protein and glyco-
protein-stained 2-D gels. Whole
saliva was subjected to isoelec-
tric focusing on a pH 3–10
nonlinear IPG strip, which was
then resolved in the second
dimension on a 12.5% SDS-
PAGE gel. The resulting gels
were either stained with SYPRO
Ruby total protein stain (a) or
Pro-Q Emerald 488 glycoprotein
stain (b). Labeled are the protein
spots that were identified from
the Sypro Ruby-stained gel
either by MALDI-TOF MS or
LC-MS/MS in our previous
work [8] or by LC-MS/MS in
this work
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(100 mM Tris buffer at pH 9.5, 100 mM NaCl, and 5 mM
MgCl2). Color development was accomplished using one-
step NBT/BCIP (Pierce, Rockford, IL, USA) with agitation at
RT and was allowed to proceed until sample-free areas of the
blot began to exhibit a weak background. The blot was then
placed in a stop solution (20 mM Tris buffer at pH 2.9) and
subsequently allowed to air dry. All of the reagents contrib-
uting to the reporter system were reconstituted according to
manufacturer’s specifications. The developed lectin blots
were scanned and saved as high-resolution tiff-files.
None of the 2-D analysis software tested by us could
accurately match and/or quantitate the spots from the lectin
blots. The spots from the lectin blots were thus visually
ranked as having low, medium, high, or no reactivity to the
various lectins or stain. This ranking was done as a
comparison for all the spots across a single gel. Some of
the spots migrated to areas of the lectin blot that showed
nonspecific reactivity, meaning no definitive spot could be
observed. These spots were ranked as having a positive
reactivity (+). This same ranking system of high, medium,
and low reactivity was also carried out for both the Sypro
Ruby and the Pro-Q Emerald-stained gels.
Population Variation The range of population variation for
each lectin affinity was determined from resting whole
saliva from a group of 66 healthy adults ranging 24–
36 years of age and covering a broad racial spectrum.
Assay conditions and quantitation methods were performed
as previously described [71]. A dilution equivalent to 0.2 μl
of whole saliva was spotted onto nitrocellulose along with
0.12 and 0.3 μg of the commercially available blood
glycoprotein, glycophorin (Sigma-Aldrich, St. Louis, MO,
USA). These dot blots were developed and visualized as
described above in “Lectin Blotting”. The bound lectin was
then quantitated using SigmaScan (Systat Software, Chi-
cago, IL, USA). Finally, the measured reactivity was
normalized against the glycophorin standard in order to
determine the population variation.
Results
Protein Identification from 2-D Gels Resting whole saliva
was collected from two healthy male individuals. The saliva
was pooled, clarified of epithelia cells and other debris, and
precipitated with ethanol. The salivary proteins were then
separated on a two-dimensional gel that was stained with
Sypro Ruby total protein stain (Fig. 1a). The spots from this
gel image were matched to the 2-D gel image that our
group had previously published [8, 28]. Of the 105 spots
that were previously identified from whole saliva of one
healthy female individual, we were able to match all the
spots from our pooled males except for nine spots (numbers
17, 18, 54, and 100–105). To verify that we had accurately
matched the gel spots and to examine for individual
differences, 18 spots (numbers 19, 23, 24, 27, 28, 51, 62,
64, 65, 67–69, 76, 78, 81, 82, 88, and 96), which were
previously identified, were excised along with 78 additional
spots that had not previously been identified. After in-gel
digestion with trypsin, the resulting peptides were analyzed
by LC-MS/MS. The complete list of protein identifications
is provided in the Supplemental Table. The higher abundant
proteins in our repeated spot identification matched our
previous work. As expected, we were able to identify a
number of new lower abundant proteins using LC-MS/MS,
compared to our previous work that primarily employed
MALDI-TOF (matrix-assisted laser desorption ionization-
time of flight) MS. As commonly observed by others, rarely
did a single gel spot yield a single protein identification.
However, for many of the spots, based on the number of
unique peptides that were identified through MS/MS, there
was one higher abundant protein with a number of much
lower abundant proteins. Of the 78 additional spots picked,
69 spots (numbers 106–174) yielded a positive identifica-
tion. When comparing these protein identifications to our
previous work with whole saliva that used both 2-D gel
electrophoresis and bottom-up LC-MS/MS and MALDI-
TOF MS approaches [8], 50 new proteins were identified in
this study. The data were submitted to the database (www.
hspp.ucla.edu) that houses the compiled data from the
Human Salivary Proteome Project, representing work from
the Scripps Research Institute/University of Rochester, the
University of California—Los Angeles/University of
Southern California, and the University of California—
San Francisco.
Generation of a Glyoprofile Catalog In order to determine
the glycosylation profile of the spots observed on the total
protein stained 2-D gel, the same sample was run on
additional gels that were stained either with Pro-Q Emerald
488 glycoprotein stain (Fig. 1a) or transferred and probed
with a panel of 15 lectins representing six monosaccharide-
specific categories (Fig. 2 and Supplemental Figures). The
primary monosaccharide preference and the binding spec-
ificity for each of the lectins are described in Table 1. For
most of the 2-D gels used in this study, 250 μg total protein
was loaded onto the isoelectric focusing strip. However,
some of the lectin blots appeared overloaded and had a high
background at this concentration, thus making it very
difficult to distinguish individual spots. For these blots
(lectin AAL, ConA, JAC, PSA, SNA, and WGA), the total
protein loading was 50 μg to reduce the background and
nonspecific binding.
The spots from the Pro-Q Emerald-stained gels and the
lectin blots (Figs. 1b, 2, and Supplemental Figures) were
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matched to the Sypro-stained gel (Fig. 1a) from which the
spots had been identified. In order to generate a catalog (see
Supplemental Table), the spots on the lectin blots and the
Pro-Q Emerald-stained gel were visually rated as having a
high, medium, low, or no reactivity to a particular lectin or
to the stain. The lectin blots were repeated multiple times
and showed that the 2-D pattern of the individual lectin
reactivity was reproducible with regard to the relative
ranking of individual spots. The reproducibility of ranking
is due to the assay conditions, which typically can be
quantitated over a tenfold range of concentration [71].
However, any spot demonstrating color saturation would
narrow the quantitation range. For certain lectins described
above, this problem was addressed by reducing the total
amount of protein loaded in the 2-D gel.
For some of the lectin blots, there is a large area of
nonspecific reactivity near the acidic and/or basic end of the
gel (i.e., Fig. 2e, basic region). Spots which migrated to
these areas of nonspecific reactivity were rated as having a
positive reactivity (+) in the Supplemental Table, even
though they were not clearly defined. Since these areas did
not stain with Sypro Ruby and in the absence of salivary
proteins none of the reagents used individually or in concert
yielded a visible background, we speculate that these areas
of reactivity result from free, charged oligosaccharides of
varying chain lengths and branching.












































































































Fig. 2 2-D lectin blots. Two-
dimensional gels containing
whole saliva were transferred
and probed with either lectin
DSL (a), LEL (b), UEA I (c),
AAL (d), or WGA (e). The
spots were matched to the Sypro
Ruby-stained gel shown in Fig.
1a and scored for having high,
medium, low, or no reactivity
(Supplemental Table)
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This type of scoring system, which is a comparison for
all the spots across a single gel or lectin blot, does not take
into account the degree of protein staining. Therefore, the
Sypro Ruby-stained gel was also scored the same way
(Supplemental Table) so that the lectin reactivity can also
be compared to the Sypro Ruby staining. The degree of
protein staining is dependent on at least two factors:
molecular weight and the availability and accessibility of
the stain to its binding sites. For instance, proteins at high
molecular weight that stain darkly have a lower molar
concentration than lower molecular proteins that stain at the
same darkness. In addition, Sypro Ruby stain binds to basic
amino acids and the polypeptide backbone [72, 73], and
therefore, the effects of amino acid content and glycosyl-
ation on stain binding are, in theory, thought to be minimal.
However, the manufacturers of newer fluorescent stains claim
that their stain binds better to glycoproteins than Sypro Ruby.
In regards to staining proteins from whole saliva, we found
that two of these newer stains resulted in lower staining
intensity (GE Healthcare Deep Purple and Bio-Rad Flamin-
go), and only one stain worked slightly better than Sypro
Ruby (Pierce Krypton). Though this type of scoring system
provides only a semi-quantitative analysis, it is important
because it helps provide insight to the secondary affinity of a
particular lectin and/or the abundance of a particular oligo-
saccharide. This type of analysis using a total blot comparison
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has been very useful for developing a dental caries risk
assessment test [71, 74]. However, since each lectin has a
different binding constant to its substrate, this type of
quantitation system is only useful for comparing spots from
the same blot and for comparing the reactivity of a particular
lectin between various individuals.
Lectin Blot Results Generally, the best way to quantitate all
of the lectin blots in a large scale study would be to
normalize against one universal, housekeeping protein such
as the use of actin in quantitative western blot analysis. This
type of normalization helps to account for differences in
protein loads and development times for the lectin blots.
The predominant, housekeeping protein in whole saliva is
α-amylase. However, the copy number of the salivary
amylase gene was shown to vary for different populations
of individuals [75], and we, so far, have not identified a
good candidate. In addition, neither this protein nor any
other protein possesses equal amounts of all possible glycan
structures. For example, lectins DSL, LEL, and WGA all
recognize (β-1,4)-linked N-acetylglucosamine, but each
lectin recognizes a different glycan structure containing
this oligosaccharide and the (β-1,4)-linkage. Therefore,
when comparing the spot pattern from the various lectin
blots, each lectin shows a distinct pattern even if they
belong to the same sugar-specific category (Fig. 2 and
Supplemental Figures). To illustrate, spot 9 (serotransferrin)
demonstrates a low reactivity to lectins DSL and WGA but
a high reactivity to lectin LEL (Fig. 2a, b, and e). The
power of this type of scoring is that it indicates that
serotransferrin is predicted to have predominately (β-1,4)-
linked N-acetylglucosamine trimer or tetramer as part of the
attached oligosaccharide.
Another example of how this type of scoring provides
an added dimension of knowledge is the reactivity of
the lectin panel to a train of zinc-alpha-2-glycoprotein
(ZA2G) spots (numbers 60–63). Each spot showed a
different pattern of reactivity to the lectin panel (Supple-
mental Table). Work by Löster and Kannicht [76]
demonstrated that enzymatic desialylation shifts the pI
toward the basic pH along with decreasing the molecular
weight, while chemical deglycosylation only decreases the
molecular weight. These spots do show differential
reactivity to the lectins (Mal II and SNA) that primarily
bind to sialic acid (Supplemental Table). However, other
post-translational modifications may also be responsible
for the shift in pI. Although other types of glycosylations
are highly unlikely responsible for the shift in pI, we do
observe differential reactivity to these spots for other
members of the lectin panel. For example, both lectins
AAL and UEA I recognize α-monofucosyl oligomers, but
only lectin AAL reacted strongly to all of the spots,
suggesting that ZA2G contains fucose (α-1,6)-N-acetyl-
glucosamine and/or fucose (α-1,3)-N-acetyllactosamine
residue(s) (Fig. 2c–d). On the other hand, lectin UEA I
displayed differential recognition to these same spots, in
which spot 60 had no reactivity, spots 61–62 had strong
reactivity, and spot 63 had weak reactivity (Supplemental
Table). Therefore, the proteins in spots 61 and 62 are
likely to have a second α-monofucosyl oligomer consist-
ing of fucosyl (α-1,2) galactosyl (β-1,4) N-acetylglucos-
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binds blood group O cells and has been used to determine
secretor status.
Of the 166 2-D gel spots, which have been identified, all but
eight spots reacted to our lectin panel (Supplemental Table).
This indicates that most of the abundant salivary proteins are
glycosylated and is consistent with the fact that the majority of
the proteins in saliva are secreted as extracellular proteins.
Spot 31 showed the highest reactivity to the lectin panel and
was identified as α-amylase. This protein is the most abundant
protein found in saliva and was found in 88 of the 2-D gel
spots examined. Other highly reactive spots contained
carbonic anhydrase VI or polymeric-immunoglobulin receptor.
The second most abundant protein in terms of spot number
was serum albumin. Since serum albumin is only glycosylated
in a few of the genetic variants [77], it will not normally
contribute to the glycoprofile.
By observing the reactivity of all of the lectins to the
various spots (Supplemental Table), the following general
trend was observed. As the molecular weight increases, the
more likely that a particular spot reacts to the lectin panel.
Larger proteins may have more potential glycosylation sites
and may have more heterogeneity or more complex
oligosaccharides than smaller proteins. Only a few spots
showed no reactivity to any of the lectins; this includes spot
numbers 64, 83, 84, 95, 170, and 172–174. Interestingly, all
of the “unreactive” spots had a molecular weight of 40 kDa
or less. Since most of the spots reacted to the lectin panel,
several members of the lectin panel were used on extracts
from the proteobacteria Myxococcus xanthus to test the
specificity of the lectins (data not shown). The degree and
pattern of reactivity of these lectins was distinct for human
whole saliva and was vastly different when comparing
results shared with us on the archaeon Methanosarcina
acetivorans (Leon-Russell D and Denny PC, 2007, person-
al communication), indicating that the reactivity pattern was
specific for human whole saliva.
Lectins bind to only the exposed glycan structures of a
complex oligosaccharide. These structures are involved in
biological activity. By comparing the total number of spots
that reacted with a particular lectin, Mal II demonstrated the
most reactivity by reacting with 128 of the 166 2-D gel spots
(Table 2). This suggests that most of the salivary proteins
contain a (α-2,3)-linked sialic acid residue. On the other end
of the scale are lectins PSA and AAL, which reacted with the
least number of spots (54 of 166 spots), indicating that
fucose (α-1,6)-N-acetylglucosamine, fucose (α-1,3)-N-ace-
tyllactosamine, and α-mannose oligosaccharides containing
an N-acetylchito-biose-linked α-fucose residues are the least
likely of the glycan structures to be found attached to
salivary proteins. Since both of these blots had the lower
protein loads (see “Materials and Methods” section), each of
the low loaded blots were compared to the original high load
blots to find new spots that could be detected in the higher
loaded blots. No new spots were detected in the higher
loaded blots, and a number of spots blended into the higher
background or merged with neighboring spots.
Coreactivity Between Two Lectins To determine the glycan
structures that are most and least often found together, the
number of spots showing coreactivity between two lectins
was counted (Table 2), and the percent of coreactivity
between two lectins was calculated (Table 3). Comparing
the data from the various rows in Table 3, the top three
lectins showing the most coreactivity with each of the
lectins from the panel were BPL, MAL I, and MAL II. Not
surprisingly, these were among the top four lectins reacting
to the most spots (Table 2). LEL, JAC, and PSA coreacted
with the least number of spots. Although JAC and PSA
were among the least reactive lectins (Table 2), LEL has
relatively moderate total coreactivity. This profile becomes
more apparent by comparing the data from the various
columns in Table 3, where typically the spots from lectins
demonstrating the least reactivity (Table 2) were more
likely to be recognized by multiple lectins from the panel. If
LEL was consistent with this trend, then it should fall in the
middle. Instead, the spots recognized by LEL were near the
least recognizable by multiple members of the lectin panel.
This suggests that the (β-1,4)-linked N-acetylglucosamine
trimers and tetramers primarily recognized by LEL are less
likely to be associated with other glycan structures or that
other glycan structures maybe inhibiting the binding of
LEL. Additional studies using deglycosylating enzymes
would help to provide insight as to whether the latter is
true, and other studies are necessary to determine if the
LEL coreactivity pattern for these two individuals is also
true for a broader population.
Population Variation To address the possibility that the
oligosaccharides cataloged in this study exhibit levels of
variation which might lead to correlations with other
diseases, we assessed the range of population variation for
each of the lectins (Table 1). Based on dot-blot quantifica-
tion of whole resting saliva, the population variation for the
individual oligosaccharide motifs ranged from 9,000-fold
for the LEL ligand to 3.5-fold for the ConA ligand.
Previous work showed that normal individual variation for
the concentration of mucins in resting saliva [78] and the
concentration of oligosaccharide ligands for DSL, BPL,
HHL, and MALI (unpublished) rarely exceed ±30% of an
individual’s mean. Thus, individual variation is generally
less than population variation and supports the possibility
that the amount of variation of an oligosaccharide in the
population may have functional significance.
A comparison of population variation (Table 1) with
coreactivity (Tables 2 and 3) reveals that two of the three
lectins (PSA and JAC) showing the least coreactivity also
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exhibited the least population variation. One can speculate
that while humans appear to have substantial amounts of
these oligosaccharides, the distribution of the oligosacchar-
ides is more selective than for most other lectin ligands.
Furthermore, since PSA and JAC demonstrated the least
amount of coreactivity with each other, it suggests that this
selectivity is targeted, in part, to different groups of
proteins. In contrast, LEL, which is also in the least
coreactive group, showed the greatest amount of population
variation and appeared to be rare in some individuals. The
fact that LEL exhibited the least coreactivity with PSA and
JAC suggests that its selectivity is also targeted to different
glycoproteins than either of them.
Glycoprotein Stain Comparison In comparing the lectin
blots to the Pro-Q Emerald glycoprotein-stained gel
(Supplemental Figures), the lectins reacted with more spots
than did the glycoprotein stain (Supplemental Table) and,
therefore, demonstrated that the glycosylation pattern is
more widespread than suggested by the glycoprotein-
stained gel. This difference may be due in part to the fact
that lectin probing is more sensitive than Pro-Q Emerald
staining, as the alkaline phosphatase reporter is amplifying
the lectin blot signal. Also, the Pro-Q Emerald stain
appeared to have preference for particular glycan structures.
For example, Pro-Q Emerald-stained spots recognized by
lectins AAL and ConA more than 90% of the time but only
stained spots recognized by lectin LEL less than 50% of the
time (Table 3). Although the overall sensitivity may be
weaker, the Pro-Q Emerald stain was very specific for
glycoproteins because every spot which was stained also
reacted with at least one lectin.
Discussion
The power of 2-D gel electrophoresis is that it can resolve
post-translationally modified protein entities into separate,
multiple spots. These differences are observed often as a
“train” of spots, e.g., salivary α-amylase (spot numbers
29–31, 33–34, and 36–54) and carbonate dehydratase VI
(numbers 70–75). Our work demonstrates that more
information can be obtained on protein glycosylation when
2-D gels are combined with glycoprotein staining and lectin
blotting. A number of studies have used glycoprotein
staining to evaluate whether a protein within a spot is
glycosylated [69, 79–82]. However, for our human whole
saliva study, the glycoprotein staining method missed 40%
of the spots that were recognized by the lectins.
The glycosylation for several of the proteins identified
from the 2-D gel have been previously characterized by
other groups using a number of different techniques. Larsen
et al. [83] used titanium dioxide chromatography and mass




















PSA ConA GNL HHL BPL VVA DSL LEL WGA MAL
II
SNA PQE
AAL 54 45 39 49 43 45 43 44 46 48 41 30 42 46 42 49
UEA I 45 63 36 54 41 54 57 51 57 50 53 47 44 52 44 46
JAC 39 36 59 48 35 43 45 52 50 46 38 25 36 50 41 39
MAL I 49 54 48 109 47 63 69 82 79 76 58 39 55 97 61 66
PSA 43 41 35 47 54 48 44 46 48 44 46 33 29 46 43 51
ConA 45 54 43 63 48 74 63 62 65 57 47 41 56 65 52 60
GNL 43 57 45 69 44 63 91 75 74 66 56 45 53 80 56 58
HHL 44 51 52 82 46 62 75 109 79 75 54 38 53 93 64 64
BPL 46 57 50 79 48 65 74 79 101 75 59 50 54 85 62 70
VVA 48 50 46 76 44 57 66 75 75 95 55 40 52 63 61 68
DSL 41 53 38 58 46 47 56 54 59 55 69 40 54 42 50 44
LEL 30 47 25 39 33 41 45 38 50 40 40 78 39 40 36 38
WGA 42 44 36 55 29 56 53 53 54 52 54 39 62 53 53 54
MAL II 46 52 50 97 46 65 80 93 85 63 42 40 53 128 60 74
SNA 42 44 41 61 43 52 56 64 62 61 50 36 53 60 70 56
PQE 49 46 39 66 51 60 58 64 70 68 44 38 54 74 56 94
This table demonstrates the number of spots showing cross-reactivity between two lectins or a lectin and the Pro-Q Emerald 488 stain (PQE).
Spots showing only low, medium, or high reactivity were counted. Data in bold are the number of spots from a total of 166 spots, which reacted
with a particular lectin or was stained with Pro-Q Emerald
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spectrometry to identify 45 proteins from human whole
saliva that had 97 glycosylation sites that were modified
with sialic acid. From 2-D gels, we too identified 11 of the
45 proteins: polymeric-immunoglobulin receptor, salivary
α-amylase, zinc alpha-2-glycoprotein 1, DMBT1 (glyco-
protein 340), lactotransferrin precursor, mucin 5-B, lacto-
transferrin, lactoperoxidase, immunoglobulin Mu chain C
region, kallikrein 1, and myeloperoxidase. All of the spots
containing these proteins reacted with one or both of the
sialic acid recognizing lectins, SNA and MAL II, though
the level of reactivity may have varied for the various
isoforms. Others have used lectin affinity chromatography
to purify glycoproteins/glycopeptides from complex mix-
tures such as serum, bile, or saliva. These same lectins used
for affinity purification also reacted to some of the spots
from our 2-D gel that contained the same proteins.
Examples include the following proteins: polymeric-immu-
noglobulin receptor was purified from bile using lectins
ConA and WGA [84]; α-amylase was purified from whole
saliva using ConA [85]; immunoglobulin Mu chain C
region was purified from serum using multi-lectin affinity
chromatography and was found in the ConA and WGA
displacement fractions [86]; and immunoglobulin alpha-1
chain C region was purified from serum using ConA, UEA
I, and SNA [87]. Since the glycan structure can be tissue- or
cell-type specific, the glycosylation for a particular protein
found in saliva may not always correlate with those found
on that same protein when it comes from another source.
Lectin affinity chromatography is a popular method to
capture glycoproteins for proteomic identification and
characterization [88–90]. For this strategy, the most
commonly used lectins are ConA and WGA, which bind
to a broad range of monosaccharides and glycan structures.
Our work suggests that ConA and WGA do not capture all
glycoproteins from human whole saliva, and other lectins
have higher reactivity for salivary glycoproteins. In terms
of recognizing the most spots, ConA was moderately
reactive and WGA was poor (Tables 2 and 3). Lectin Mal
II reacted to the most spots and coreacted at least 83% of
the time to the spots that were recognized by the majority of
the other lectins. However, for the lectins VVA, DSL, and
LEL, the ability to coreact dropped down to 51–66%.
Therefore, in order to truly capture the majority of all the
glycoproteins or glycopeptides, a multi-affinity column
would be needed.
The advantage of using a panel of lectins versus an
individual lectin is that one can gain insight about which
glycan structures are most and least frequently associated




















PSA ConA GNL HHL BPL VVA DSL LEL WGA MAL
II
SNA PQE
AAL 100 71 66 45 80 61 47 40 46 51 59 38 68 36 60 52
UEA I 83 100 61 50 76 73 63 47 56 53 77 60 71 41 63 49
JAC 72 57 100 44 65 58 49 48 50 48 55 32 58 39 59 41
MAL I 91 86 81 100 87 85 76 75 78 80 84 50 89 76 87 70
PSA 80 65 59 43 100 65 48 42 48 46 67 42 47 36 61 54
ConA 83 86 73 58 89 100 69 57 64 60 68 53 90 51 74 64
GNL 80 90 76 63 81 85 100 69 73 69 81 58 85 63 80 62
HHL 81 81 88 75 85 84 82 100 78 79 78 49 85 73 91 68
BPL 85 90 85 72 89 88 81 72 100 79 86 64 87 66 89 74
VVA 89 79 78 70 81 77 73 69 74 100 80 51 84 49 87 72
DSL 76 84 64 53 85 64 62 50 58 58 100 51 87 33 71 47
LEL 56 75 42 36 61 55 49 35 50 42 58 100 63 31 51 40
WGA 78 70 61 50 54 76 58 49 53 55 78 50 100 41 76 57
MAL II 85 83 85 89 85 88 88 85 84 66 61 51 85 100 86 79
SNA 78 70 69 56 80 70 62 59 61 64 72 46 85 47 100 60
PQE 91 73 66 61 94 81 64 59 69 72 64 49 87 58 80 100
The percentages in this table were calculated from the data listed in Table 2 where the data in bold were used as the 100% value for all
percentages listed for that particular column. When interpreting the data from a particular row, the data indicates how well the lectin listed in that
particular row coreacted to the same spots recognized by the lectins listed in the various columns. When analyzing the data from a particular
column, the data indicates how well each of the lectins from the various rows reacted to the same spots that were recognized by the lectin listed in
the column of interest
PQE Pro-Q Emerald 488 staining
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together. Since many glycoproteins contain more than one
glycosylation site, the association of staining with multiple
lectins may originate from different glycosylation sites on
the same glycoprotein. For instance, one protein we
identified was immunoglobulin A1 (IgA), which is the
principle antibody found in external secretions and thought
to be responsible for the protection of the mucosal surfaces
from the external environment. Human IgA1 contains two
N-linked glycosylation sites in the second domain and in
the secreted tailpiece along with three to five O-linked
oligosaccharides in the hinged region. Structural analysis of
human IgA1 revealed that there are three major N-linked
disialylated biantennary complex-type structures containing
Gal (β-1,4) GlcNAc [91–93]. A subpopulation (7%) of
IgA1 has N-linked oligosaccharides that are triantennary
with the outer branched substituted with fucose (α-1,3) [94].
The O-linked oligosaccharides consist of N-acetylgalactos-
amine with or without a terminal D-galactose in the (β-1,3)
configuration [95].
Aberrant glycosylated IgA has been associated with
nephropathy and liver diseases. In patients with IgA
nephropathy, IgA1 shows increased levels of sialylation,
and the O-glycans were found to be incompletely galacto-
sylated [95, 96], thereby exposing a terminal N-acetylga-
lactosamine. Lectins have been used to characterize the
glycoforms from serum of these patients. To study O-linked
glycans, lectin VVAwas used to detect the ungalactosylated
N-acetylgalactosamine moiety, while the lectins Arachis
hypoaea (peanut agglutinin (PNA)) and Amaranthus cau-
datus were employed to detect the complete galactosylated
Gal (β-1,3) GalNAc moiety [97]. N-linked glycosylations
were characterized with lectin Triticum vulgaris to detect
the terminal GlcNAc moiety and Erythrina crystagalli to
detect terminal D-Gal of N-linked moieties [97]. Sialylation
was characterized with MAL II to detect (α-2,3)-sialic acid
and SNA to detect (α-2,6)-sialic acid [96]. Although not all
of these lectins were utilized in the current study, the value
of this approach is supported by use of other lectins, which
have a similar primary binding specificity. By comparing
spot numbers 35 and 112, which both contain IGA1 and
demonstrate a difference in both MW and pI, this alteration
appears to be the result of variation in both N- and O-linked
glycosylations.
Beyond their use as carbohydrate recognition tools,
lectins provide valuable insight to the potential function of
a particular oligosaccharide moiety. One such function is
the oligosaccharide-mediated interaction that is involved in
cell adhesion of normal and pathogenic processes [98–100].
Therefore, it is not surprising that carbohydrate-binding
specificities have been demonstrated for a variety of
microbes (viruses, bacteria, fungi, and parasites). The most
actively studied bacteria is Helicobacter pylori, one of the
pathogens responsible for gastric ulcers, and has been
associated with at least seven carbohydrate-binding specif-
icities, including the fucosylated Lewis B blood group
antigen [99, 101–103]. Another example is the galactosyl
(β-1,4) N-acetylglucosamine ligand preferred by oral
bacterium Fusobacterium nucleatum, a potential pathogen
for periodontal disease [104]. These specific, exposed, host-
cell oligosaccharides will promote colonization of teeth and
the mucosal surfaces of the oral cavity and digestive tract, a
critical factor in initiating infection. Therefore, lectins
identifying these host-cell oligosaccharides may be useful
to titrate a host’s potential for interacting with a microbe’s
surface lectins or to act as surrogates for the microbe’s
binding preferences in screening operations.
Salivary mucins and agglutinins bind a variety of oral
microbes [104–107] and thereby play a fundamental role in
protection against oral pathogens. Mucins have been shown to
possess an enormous repertoire of glycan structures [108–
111]. Lectins typically have been used to identify or verify the
interacting glycoforms on these large glycoproteins present in
saliva [104–107]. Thus, it was somewhat surprising that in the
present study, many of the same glycoforms are widely
distributed among the salivary proteome. This suggests that
the host glycoprotein interactions with planktonic microbes
might be more broadly based than expected and could provide
protection from colonization by competing with the solid-
phase receptors and/or promoting agglutination.
Differences in the total amount of selected oligosacchar-
ides, as quantitated in resting whole saliva by dot-blot, has
been correlated with levels of caries disease in young adults
and is believed to be useful as a predictor of caries
susceptibility in children [71, 74]. During development of
a test for assessing this caries susceptibility, it was shown
that certain oligosaccharides are strongly positively corre-
lated with caries history, while others are negatively
correlated. It is the ratio of these two groups of oligosac-
charides that determines an individual’s susceptibility to
caries. A question that remains is whether there are a few
glycoproteins in saliva possessing the appropriate oligosac-
charides, which are positively or negatively involved in the
caries process, or if the mechanism is founded on a broadly
based, mass action as suggested by the 2-D gel lectin blots.
Further studies are needed to resolve this issue.
By understanding global changes in the salivary glyco-
sylation profile, we will gain important insight on the
glycoforms present in saliva. This knowledge could provide
potential targets for diagnostic tools and therapeutic treat-
ments. In addition, specific glycolyl-targets identified could
be used to monitor the success of a treatment for a
particular disease. For example, cancer has been shown to
cause altered patterns of glycosylation [19]. If a cancer is
responding to treatment and has not spread, the altered
glycosylation pattern should return to normal. Saliva has
clinical advantage over other body fluids such as blood
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serum and urine since it provides an easy, abundant,
noninvasive means to collect samples for diagnostic testing.
Biomarkers from saliva have been successfully used to aid
in the diagnosis of a number of diseases such as
sarcoidosis, rheumatoid arthritis, breast cancer, tuberculo-
sis, lymphoma, and Sjögren’s syndrome [1]. Our group is
using a wide variety of proteome techniques [2, 8, 28, 29]
to discover disease-related biomarkers from saliva in the
hopes of developing a routine saliva diagnostic test to
detect, diagnose, and monitor the progression of disease.
This research provides a visible 2-D gel glycosylation
reference map, which puts in place one more tool for the
discovery of biomarkers in saliva. Ultimately, any glyco-
sylation biomarker identified through 2-D lectin blot
analysis must be studied in detail through MS/MS analysis
to locate the glycosylation site(s), to completely identify the
entire glycan structure(s) attached, and to understand all the
post-translational modifications associated with a particular
protein of interest.
Supporting Information Available
A complete spreadsheet listing the proteins identified for
each spots, the reactivity of each of the spots to the lectin
panel, and other information such as the experimental and
theoretical weights for each of the proteins identified are
available in the supplemental material along with the blot
images for the entire lectin panel.
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